Identification of novel variants underlying non-syndromic primary ovarian insufficiency using a targeted NGS gene panel

Our main conclusion is that the development of a test integrating clinical, ultrasound, biochemical (OvAge©) and genetic data could substantially enhance early identification of women at risk of POI and offer opportunities for fertility preservation, such as oocyte cryopreservation or prioritizing reproductive efforts.